Registrations are now closed
The Dialogue will explore the health challenges of Australia’s ageing population. Entrepreneurs, decision makers, government officials, researchers, academics and business leaders will have the opportunity to exchange ideas and together explore:
The 2017 Dialogue will examine if health technology can help Australia rise to the challenge of adapting to the ageing face of the nation, in order to mitigate issues of rising and shifting healthcare costs and needs. Read the Issues Paper (PDF).
It will highlight ATSE’s consistent commitment to leading the public discussion on Australia’s future prosperity with a focus on using the best of Australian and international technologies to address our national challenges.
Subscribe to the event e-list for notification as details are released.
This major ATSE event also incorporates ATSE’s Annual Innovation Dinner on 14 June where the Clunies Ross Awards for innovation commercialisation will be presented. This year’s Keynote speaker is 2017 Australian of the Year, Professor Alan
Mackay-Sim, stem cell and neuroscientist.
The Clunies Ross Awards are presented in three separate categories: Entrepreneur of the Year, Knowledge and Commercialisation, and Innovation. Now in its 27th year of being presented, the Clunies Ross Awards will again recognise the outstanding applications of science and technology that
provide economic, social and/or environmental benefit to Australia.
As the nation’s premier annual awards for innovation commercialisation the Clunies Ross Awards bring together Australia’s top leaders and innovators from research, industry, academia and government and provide a valuable networking opportunity.
Alan Mackay-Sim is a stem cell and neuroscientist and 2017 Australian of the Year who worked at Griffith University from 1987 to 2015, when he retired and was appointed Emeritus Professor. His research has encompassed the human sense of smell and how the olfactory sensory neurons in the nose get regenerated throughout life.
He is a world leader in spinal cord injury research using nasal olfactory cells. He led a team in a world-first clinical trial in which the patient’s own olfactory cells were transplanted into the injured spinal cord in the first stages of a therapy to treat human paraplegia. He established the National Centre for Adult Stem Cell Research in 2006 and built an adult stem cell bank with cells from more than 300 people with different neurological conditions. These stem cells are used to identify the biological bases of neurological diseases using genomics, proteomics and cell function assays and this work is leading to new drug therapies.
Sponsorship opportunities are available for both the Innovation Dinner and the Dialogue.
Registrations are now closed
We understand that circumstances may change which have an effect on your ability to attend the event after it has been booked and paid for. Should your attendance plans change the following will apply:
Name change: A substitute delegate can be nominated to attend in your place at any time up to 24 hours prior to the start of the event. There is no fee for a change in delegate name up to this point. A name change within 24 hours of the start of the event will incur a 25 per cent administration fee.
Cancellation: Should you be unable to find a replacement and seek a refund, the following applies:
All name changes or cancellations must be advised in writing by email to email@example.com
View the Event Cancellation and Refund Policy.
To book tickets, please sign in with your username and password if you are not already logged in or use the "forgot my password or my username" links on the Sign In page to retrieve your details. If you have not previously registered for an event please create an account.
Promoting Australia's advancement through technology